OpenURL Connection Search

Select item for more details and to access through your institution.

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study.
Published in:
American Journal of Hematology, 2023, v. 98, n. 1, p. 11, doi. 10.1002/ajh.26741
By:
- Kanter, Julie;
- Thompson, Alexis A.;
- Pierciey, Francis J.;
- Hsieh, Matthew;
- Uchida, Naoya;
- Leboulch, Philippe;
- Schmidt, Manfred;
- Bonner, Melissa;
- Guo, Ruiting;
- Miller, Alex;
- Ribeil, Jean‐Antoine;
- Davidson, David;
- Asmal, Mohammed;
- Walters, Mark C.;
- Tisdale, John F.
Publication type:
Article
Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Published in:
Molecular Cancer, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12943-018-0896-8
By:
- Zhang, Keqiang;
- Wang, Jinhui;
- Yang, Lu;
- Yuan, Yate-Ching;
- Tong, Tommy R.;
- Wu, Jun;
- Yun, Xinwei;
- Bonner, Melissa;
- Pangeni, Rajendra;
- Liu, Zheng;
- Yuchi, Tiger;
- Kim, Jae Y.;
- Raz, Dan J.
Publication type:
Article
Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial.
Published in:
American Journal of Hematology, 2020, v. 95, n. 9, p. E239, doi. 10.1002/ajh.25867
By:
- Tisdale, John F.;
- Pierciey, Francis J.;
- Bonner, Melissa;
- Thompson, Alexis A.;
- Krishnamurti, Lakshmanan;
- Mapara, Markus Y.;
- Kwiatkowski, Janet L.;
- Shestopalov, Ilya;
- Ribeil, Jean‐Antoine;
- Huang, Wenmei;
- Asmal, Mohammed;
- Kanter, Julie;
- Walters, Mark C.
Publication type:
Article
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.
Published in:
Cancer Communications, 2024, v. 44, n. 8, p. 884, doi. 10.1002/cac2.12589
By:
- Choi, Sung Hee;
- Myers, Jay Thomas;
- Tomchuck, Suzanne Louise;
- Bonner, Melissa;
- Eid, Saada;
- Kingsley, Daniel Tyler;
- VanHeyst, Kristen Ashley;
- Kim, Seong‐Jin;
- Kim, Byung‐Gyu;
- Huang, Alex Yee‐Chen
Publication type:
Article

Found: 4

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study.

Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.

Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial.

Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.